• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性运动感觉神经病和相关疾病:一个不断发展的领域。

Charcot-Marie-Tooth disease and related disorders: an evolving landscape.

机构信息

MRC Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.

出版信息

Curr Opin Neurol. 2019 Oct;32(5):641-650. doi: 10.1097/WCO.0000000000000735.

DOI:10.1097/WCO.0000000000000735
PMID:31343428
Abstract

PURPOSE OF REVIEW

Charcot-Marie-Tooth (CMT) disease and related disorders are the commonest group of inherited neuromuscular diseases and represent a heterogeneous group of disorders. This review will cover recent advances in genetic diagnosis and the evolving genetic and phenotype landscape of this disease group. We will review recent evidence of the increasingly recognized phenotypic overlap with other neurodegenerative conditions including hereditary spastic paraplegia, hereditary ataxias and mitochondrial diseases and highlight the importance of deep phenotyping to inform genetic diagnosis and prognosis.

RECENT FINDINGS

Through whole exome sequencing and multicentre collaboration new genes are being identified as causal for CMT expanding the genetic heterogeneity of this condition. In addition, an increasing number of variants have been identified in genes known to cause complex inherited diseases in which the peripheral neuropathy is part of the disorder and may be the presenting feature. The recent discovery of a repeat expansion in the RFC1 gene in cerebellar ataxia, neuropathy, vestibular areflexia syndrome highlights the prevalence of late-onset recessive conditions which have historically been considered to cause early-onset disease.

SUMMARY

CMT is an evolving field with considerable phenotypic and genetic heterogeneity and deep phenotyping remains a cornerstone in contemporary CMT diagnostics.

摘要

目的综述

Charcot-Marie-Tooth (CMT) 疾病和相关疾病是最常见的遗传性神经肌肉疾病群体,代表了一组异质性疾病。本综述将涵盖遗传诊断的最新进展以及该疾病群体遗传和表型不断变化的图景。我们将回顾最近关于与其他神经退行性疾病(包括遗传性痉挛性截瘫、遗传性共济失调和线粒体疾病)日益认识到的表型重叠的证据,并强调深入表型分析对遗传诊断和预后的重要性。

最新发现

通过全外显子组测序和多中心合作,新的基因被确定为 CMT 的致病原因,扩大了该疾病的遗传异质性。此外,在已知导致复杂遗传性疾病的基因中,越来越多的变异被发现,其中周围神经病是该疾病的一部分,也可能是其表现特征。最近在小脑共济失调、神经病、前庭反射消失综合征的 RFC1 基因中发现重复扩展,突出了迟发性隐性疾病的普遍性,这些疾病在历史上被认为会导致早发性疾病。

总结

CMT 是一个不断发展的领域,具有相当大的表型和遗传异质性,深度表型分析仍然是当代 CMT 诊断的基石。

相似文献

1
Charcot-Marie-Tooth disease and related disorders: an evolving landscape.遗传性运动感觉神经病和相关疾病:一个不断发展的领域。
Curr Opin Neurol. 2019 Oct;32(5):641-650. doi: 10.1097/WCO.0000000000000735.
2
Classifications of neurogenetic diseases: An increasingly complex problem.神经遗传性疾病的分类:一个日益复杂的问题。
Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):339-49. doi: 10.1016/j.neurol.2016.04.005. Epub 2016 May 27.
3
Genetic epidemiology of Charcot-Marie-Tooth disease.夏科-马里-图思病的遗传流行病学
Acta Neurol Scand Suppl. 2012(193):iv-22. doi: 10.1111/ane.12013.
4
NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.神经丝轻链蛋白N98S突变:具有异质性早发表型的显性中间型夏科-马里-图斯病的另一个病因。
J Neurol. 2016 Feb;263(2):361-369. doi: 10.1007/s00415-015-7985-z. Epub 2015 Dec 8.
5
Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations.具有或不具有其他神经系统表现的痉挛性截瘫患者的遗传起源。
BMC Neurol. 2022 May 16;22(1):180. doi: 10.1186/s12883-022-02708-z.
6
Molecular Diagnosis of Hereditary Neuropathies by Whole Exome Sequencing and Expanding the Phenotype Spectrum.全外显子组测序在遗传性周围神经病分子诊断中的应用及表型谱的扩展。
Arch Iran Med. 2020 Jul 1;23(7):426-433. doi: 10.34172/aim.2020.39.
7
Early-onset axonal Charcot-Marie-Tooth disease due to SACS mutation.早发性轴索型夏科-马里-图什病与 SACS 突变相关。
Neuromuscul Disord. 2018 Feb;28(2):169-172. doi: 10.1016/j.nmd.2017.11.008. Epub 2017 Nov 24.
8
A review of the genetic spectrum of hereditary spastic paraplegias, inherited neuropathies and spinal muscular atrophies in Africans.对非洲遗传性痉挛性截瘫、遗传性周围神经病和脊肌萎缩症的遗传谱的综述。
Orphanet J Rare Dis. 2022 Mar 24;17(1):133. doi: 10.1186/s13023-022-02280-2.
9
Next-generation sequencing in Charcot-Marie-Tooth disease: opportunities and challenges.Charcot-Marie-Tooth 病的下一代测序:机遇与挑战。
Nat Rev Neurol. 2019 Nov;15(11):644-656. doi: 10.1038/s41582-019-0254-5. Epub 2019 Oct 3.
10
Charcot-Marie-Tooth disease and other inherited neuropathies.夏科-马里-图思病及其他遗传性神经病。
Continuum (Minneap Minn). 2014 Oct;20(5 Peripheral Nervous System Disorders):1208-25. doi: 10.1212/01.CON.0000455885.37169.4c.

引用本文的文献

1
Modeling of Charcot-Marie-Tooth disease in zebrafish.斑马鱼中夏科-马里-图思病的建模
Front Mol Neurosci. 2025 Aug 4;18:1641793. doi: 10.3389/fnmol.2025.1641793. eCollection 2025.
2
p.M918W, a novel RET germline variant: a case report and literature review of the possible association of multiple endocrine neoplasia type 2B and Charcot-Marie-Tooth disease.p.M918W,一种新的RET种系变异:2B型多发性内分泌腺瘤病与夏科-马里-图斯病可能关联的病例报告及文献综述
Endocr J. 2025 Jul 1;72(7):839-845. doi: 10.1507/endocrj.EJ24-0412. Epub 2025 Apr 1.
3
BIN1 reduction ameliorates -related Charcot-Marie-Tooth neuropathy.
BIN1表达降低可改善与[具体疾病名称]相关的夏科-马里-图斯神经病。 (你原文中“-related”前缺少具体疾病名称,我按格式补充了[具体疾病名称],实际使用时请替换为准确内容)
Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2419244122. doi: 10.1073/pnas.2419244122. Epub 2025 Mar 5.
4
Twelve-month change in quantitative MRI calf muscle fat fraction in CMT1A predicts clinical change over 4 years.遗传性运动感觉神经病1型(CMT1A)患者小腿肌肉定量MRI脂肪分数的12个月变化可预测4年的临床变化。
Ann Clin Transl Neurol. 2025 Apr;12(4):756-767. doi: 10.1002/acn3.52314. Epub 2025 Feb 17.
5
Niacin ameliorates Charcot-Marie-Tooth 4B1 neuropathy without interfering with nerve regeneration.烟酸可改善4B1型夏科-马里-图斯病神经病变,且不干扰神经再生。
Brain Commun. 2025 Jan 31;7(1):fcaf039. doi: 10.1093/braincomms/fcaf039. eCollection 2025.
6
Heterozygous PNPT1 Variants Cause a Sensory Ataxic Neuropathy.杂合型PNPT1变异导致感觉性共济失调性神经病。
Eur J Neurol. 2025 Feb;32(2):e70064. doi: 10.1111/ene.70064.
7
A Novel Variant in a Charcot-Marie-Tooth Type 2: Insights from Familial Analysis.夏科-马里-图斯病2型中的一种新型变体:家族分析的见解
Genes (Basel). 2024 Nov 29;15(12):1556. doi: 10.3390/genes15121556.
8
Autophagy induction by piplartine ameliorates axonal degeneration caused by mutant HSPB1 and HSPB8 in Charcot-Marie-Tooth type 2 neuropathies.胡椒碱诱导自噬可改善由2型夏科-马里-图斯病(Charcot-Marie-Tooth type 2 neuropathies)中突变的HSPB1和HSPB8引起的轴突退化。
Autophagy. 2025 May;21(5):1116-1143. doi: 10.1080/15548627.2024.2439649. Epub 2024 Dec 27.
9
Clinical Outcome Assessments and Biomarkers in Charcot-Marie-Tooth Disease.Charcot-Marie-Tooth 病的临床结局评估和生物标志物。
Neurology. 2024 Dec 24;103(12):e210120. doi: 10.1212/WNL.0000000000210120. Epub 2024 Nov 25.
10
Evaluation of the Role of Tanshinone I in an In Vitro System of Charcot-Marie-Tooth Disease Type 2N.丹参酮 I 在 2N 型腓骨肌萎缩症体外系统中的作用评价。
Int J Mol Sci. 2024 Oct 17;25(20):11184. doi: 10.3390/ijms252011184.